Checkerspot lands $55 M in Series C round

Daniela Castillo Monagas

Checkerspot, a biotech company with award-winning design and innovation labs, closed a $55 million Series C financing led by ArrowMark Partners, with participation from Cox Enterprises and other new and existing investors. The funding aims to accelerate Checkerspot’s development and commercialization of high-performance, bio-based alternatives for everyday products.

Checkerspot launched a line of performance outdoor recreation products under its consumer brand, WNDR Alpine. This brand animates and de-risks the adoption of biobased materials – developed with Checkerspot’s technology – that can be used across a wide range of industries. Specifically, WNDR’s backcountry skis and snowboards are made with Checkerspot’s microalgae-derived oils that are formulated into polyurethane foams and cast urethanes, engineered to meet specific performance metrics in a highly demanding category. 

The company has also developed technology to upcycle waste from ski and snowboard manufacturing, leading to the creation of SpiralMade™ material, a unique composite with a variety of applications in hardgoods fabrication.

The latest proceeds accelerate Checkerspot’s expansion into new and adjacent markets including industrial applications, personal care, and food and nutrition. 

TAGGED:
Share This Article